Pulse Biosciences Names Paul LaViolette CEO-March 2024-www.financetom.com

Pulse Biosciences Names Paul LaViolette CEO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Pulse Biosciences Names Paul LaViolette CEO

Jan 10, 2025 6:14 AM

08:53 AM EST, 01/10/2025 (MT Newswires) -- Pulse Biosciences ( PLSE ) said Friday it has appointed Co-Chair Paul LaViolette as its CEO.

LaViolette also serves as a director at Edwards Lifesciences (EW) and chair of the innovation advisory board at Mass General Brigham, the company said.

Previous page： Mira Pharmaceuticals Says US DEA Finds Marijuana Analog a Non-Controlled Substance Next page： Coinbase Stock Is Trading Lower Wednesday: What's Going On?

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Mira Pharmaceuticals Says US DEA Finds Marijuana Analog a Non-Controlled Substance

May 29, 2024

09:28 AM EDT, 05/29/2024 (MT Newswires) -- Mira Pharmaceuticals ( MIRA ) said Wednesday that the US Drug Enforcement Administration has determined that the company's Mira-55 pharmaceutical marijuana analog is not a controlled substance nor a listed chemical under the Controlled Substance Act. Mira-55 is under investigation to treat adult patients with neuropathic pain as well as anxiety and cognitive...

Coinbase Stock Is Trading Lower Wednesday: What's Going On?

May 29, 2024

Coinbase Global Inc ( COIN ) shares are facing selling pressure Wednesday. The weakness in Coinbase stock appears to be due to the New York Stock Exchange’s (NYSE) newly announced collaboration with CoinDesk. What Happened: The NYSE said it will collaborate with CoinDesk Indices to launch cash-settled index options. The index options will track the CoinDesk Bitcoin Price Index (XBX),...

Oxford Lane Capital Insider Bought Shares Worth $25,002,000, According to a Recent SEC Filing

May 29, 2024

09:04 AM EDT, 05/29/2024 (MT Newswires) -- Jonathan H Cohen, Director, Chief Executive Officer, on May 28, 2024, executed a purchase for 4,630,000 shares in Oxford Lane Capital ( OXLC ) for $25,002,000. Following the Form 4 filing with the SEC, Cohen has control over a total of 4,864,728 shares of the company, with 4,864,728 shares held directly. SEC Filing:...

Israeli Shekel Slips to Weekly Low as Reports Surface of War Cabinet Disagreement on Hostage Deal

May 29, 2024

09:27 AM EDT, 05/29/2024 (MT Newswires) -- The Israeli shekel weakened to a seven-day low against the US dollar as North American trading got underway on Wednesday after local media reported the country's war cabinet disagreed over a Hamas demand to end war in a hostage deal. USD/ILS was quoted at 3.7011, up 0.85%, after the Kan public broadcaster reported...